Open Access
ARTICLE
Carcinoembryonic antigen inhibits neutrophil activation by N-formyl-methionyl-leucyl-phenylalanine
Anna PAŃCZYSZYN1 *, Anna KROP-WATOREK1,2, Maciej WIECZOREK1
1
University of Opole, Department of Biotechnology and Molecular Biology, Opole, Poland
2
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland
* Address correspondence to: Anna Pańczyszyn,
BIOCELL 2015, 39(2-3), 1-4. https://doi.org/10.32604/biocell.2015.39.001
Abstract
Carcinoembryonic antigen (CEA) is a surface glycoprotein expressed in human epithelial cells
and is released from their surface, especially during colorectal cancer. Frequently, colorectal cancer is accompanied by inflammation, where tumor-infiltrating neutrophils play an important role. CEA was also found to be
a strong chemotactic agent for neutrophils. The purpose of this study was to find out if CEA can enhance neutrophil priming and activation. Primed neutrophils were activated by N-formyl-methionyl-leucyl-phenylalanine
(formyl-MLP) and the resulting oxidative burst was measured luminometrically. Unexpectedly, in vitro priming
of neutrophils by CEA, alone or preceded by LPS, inhibited subsequent activation of these cells by formyl-MLP.
CEA may have anti-inflammatory properties
in vivo.
Keywords
Cite This Article
PAŃCZYSZYN, A., KROP-WATOREK, A., WIECZOREK, M. (2015). Carcinoembryonic antigen inhibits neutrophil activation by N-formyl-methionyl-leucyl-phenylalanine.
BIOCELL, 39(2-3), 1–4. https://doi.org/10.32604/biocell.2015.39.001